So, HEFS andits two bioactive compounds act like PPAR ligands and upregulate the expression ofPPARγ hence enhancing the level of ADN by therapeutic agents might behelpful in the treatment of obesity and overweight. Here, CFD is linked to obesity due to melanocortin 4 receptor deficiency.